Uroplasty, Inc. (UPI) Posts Strong Q1 Results
Uroplasty, Inc. (NASDAQ: UPI) reported Q1 loss of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $4.01 million versus the consensus estimate of $3.58 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DuPont Fabros Technology (DFT) Tops Q2 FFO by 8c; Boosts FY15 FFO Outlook
- Iradimed Corp. (IRMD) Tops Q2 EPS by 2c; Issues Confident Q3 Outlook, Boosts FY15 Guidance
- Titan Int'l (TWI) Tops Q2 EPS by 7c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!